http://biz.yahoo.com/bw/991026/ma_creativ_1.html
Company Press Release
Creative BioMolecules Announces New Data Supporting Development of an
OP-1-based Therapy for Parkinson's Disease
HOPKINTON, Mass.--(BW HealthWire)--Oct. 26, 1999--Creative BioMolecules,
Inc. announced today new data in support of the Company's development of
a therapy to treat Parkinson's disease. The data, presented at the
Annual Meeting of the Society for Neuroscience, indicates that OP-1
restores dopaminergic neurons in an animal model of Parkinson's disease.
Dopamine is a key chemical in the brain which enables coordinated motor
movement. Restoring the function of dopaminergic neurons may provide a
new therapeutic avenue in the treatment of Parkinson's disease.
~~~~
Judith Richards, London, Ontario, Canada
[log in to unmask]
^^^^
\ /
\ | / Today’s Research
\\ | // ...Tomorrow’s Cure
\ | /
\|/
`````
